Walleye Capital LLC reduced its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 15.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 51,370 shares of the health services provider's stock after selling 9,469 shares during the quarter. Walleye Capital LLC owned 0.09% of Maximus worth $3,835,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in MMS. UMB Bank n.a. grew its position in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares in the last quarter. Eastern Bank bought a new stake in Maximus during the fourth quarter worth approximately $29,000. V Square Quantitative Management LLC boosted its stake in Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares in the last quarter. R Squared Ltd acquired a new position in Maximus in the fourth quarter worth approximately $54,000. Finally, IFP Advisors Inc lifted its position in shares of Maximus by 62.4% during the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the last quarter. Hedge funds and other institutional investors own 97.21% of the company's stock.
Insiders Place Their Bets
In other news, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on MMS shares. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a research report on Thursday, January 2nd. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.
Get Our Latest Stock Analysis on Maximus
Maximus Stock Up 0.8 %
Shares of MMS traded up $0.56 during midday trading on Tuesday, reaching $67.46. 38,270 shares of the stock were exchanged, compared to its average volume of 548,249. The firm has a 50 day simple moving average of $67.60 and a 200-day simple moving average of $75.01. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The company has a market cap of $3.82 billion, a price-to-earnings ratio of 14.50 and a beta of 0.68. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82.
Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.78%. Maximus's payout ratio is presently 25.81%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Recommended Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.